Transcript MassBio & the Massachusetts BioPharma Cluster About MassBio About MassBio Our Mission: Foster a positive environment that enables each biotechnology company to achieve.

MassBio & the Massachusetts BioPharma Cluster
About MassBio
About MassBio
Our Mission: Foster a positive environment that enables
each biotechnology company to achieve its full potential,
making Massachusetts a world center for biotechnology.
2
About MassBio
MassBio represents nearly 620
biopharma companies, service
providers, academic institutions,
hospitals, patient organizations,
foreign agencies and other
industry stakeholders.
The 410+ biopharma members
are engaged in a wide spectrum
of research & development in life
sciences.
MassBio Services
(March 2011)
Newburyport
BioReadyTM
Communities
BioReadyCampaign
Dracut
Greenfield
Fitchburg
Leominster
Pittsfield
Hatfield
Haverhill
Lawrence
North Andover
Andover
Gloucester
Beverly
Salem
Billerica
Reading
Bedford
Burlington
Lynn
Lexington
Waltham
Chelsea
Westboro
Framingham
Watertown
Worcester
Newton
Boston
Dedham Quincy
Holliston
Grafton
Norfolk
Sturbridge
Canton
Northbridge
Tri-Town (Southfield)
Randolph
Uxbridge
Franklin Mansfield
Brockton
Gardner
Lowell
Chelmsford Tewksbury
Devens
Marlborough
Easthampton
Northampton
Holyoke
Chicopee
Westfield
Springfield
Hopkinton
West Bridgewater
Attleboro
Taunton
Platinum
Gold
Savings from 20
20-80%
%
on everything from
lab gases, lab
equipment,
supplies…
Communities
Campaign
Silver
Bronze
State & Federal
Policy
Purchasing
Consortium
Networking &
Visibility
Economic
Development
MassBio
MassBio
Membership
90+ member meetings,
4,100 attendees
Fall River
New Bedford
Annual Events
MassBioEd
Foundation
Professional
Development
Innovation Services
MassCONNECT
Pharma Days
• Investment
• Mentoring
• Partnering
MassBioEd Courses,
MassBio Committee Meetings
Plymouth
Cambridge
Everett
Somerville
Savings
MassBio negotiates a broad-based collection
of contracts and services on behalf of
member companies resulting in the most
competitive pricing, large volume rebate
incentives and specialized customer
service
5
Access to the Network
Meet new people, learn about
trends in the industry, & develop
relationships with potential
partners at our Forums.






Adventures in Biotech: The Series!
The Billion Dollar Molecule Revisited
Sex, Drugs & Rock & Roll: The story of
Viagra
The Use of Social Media in FDA Regulated
Business: Impact on Patient Recruitment,
Product Marketing & Regulatory Compliance
Catalyzing Innovation – The Critical Success
Factors for Pharma-Academia Collaboration
Everything You Wanted to Know About
Protocol Violations but were Afraid to Ask
6
Access to the Network
Connect with people you have
to know & increase your
visibility.
Annual Events




Open Houses
Supplier Series Trade Shows
Policy Breakfast
Annual Golf Classic
Members-Only
Resources





HRonline
KnowledgeBase
Careers Portal
Member News
Calendar of Events
7
Business Development
Find your next partner, collaborate, and
accelerate innovation.
•
Annual Meeting: Don’t miss our signature
scientific event for dynamic keynote presentations,
panel discussions, interactive working sessions,
poster presentations & extensive networking
opportunities (April 3-4, 2014)
•
MA CRO CMO Symposium: Now in its third
year, the Massachusetts CRO/CMO Symposium
shines a spotlight on the strength and success of the
CRO and CMO communities in the Commonwealth.
(May 5, 2014)
•
BioPharm America:
Attend this annual
parterning conference & utilize partneringONE
(September 2014)
8
Innovation Services
Pharma Days
Innovation Services
MassCONNECT
About MassBio
Innovation
Services
Accelerate early stage innovation
Business Development
Access to the Network
Savings
Advocacy
In depth gap analysis of the business model
De-risk opportunities
Define market needs
Create Connections within the industry
Get Started
Bio/pharma networks
VC and other funding networks
Collaborate with other accelerators and
incubators
Strong network to identify and source start-ups
Referrals to and from other accelerators
MassCONNECT mentoring model adopted by BayBio & Indiana Bio
10
MassCONNECT
MassChallenge
MA Tech
Transfer
Center
SoPE
MA Research
Hospitals
MassCONNECT
University of
Massachusetts
LabCentral
Tufts Medical
Center
Harvard
Innovation Services
MassCONNECT Cycle I 2014
About MassBio
 Aldatu Biosciences
Innovation
Services
Business Development
Access to the Network
Savings
Advocacy
 Point of care diagnostic for HIV drug resistance
 Resilience Pharma
 Novel molecular pathway underlying PTSD
Get Started
 MGH NewCO.
 Small molecule therapeutic for VHL disease
 GlucoWise
 Non-invasive glucometer for Diabetics
Aldatu and Resilience semi-finalists in OneStart
12
GlucoWise winner MIT/Sloan Building Global Innovators
Advocacy
About MassBio
Innovation Services
Business Development
Access to the Network
Savings
Advocacy
Get Started
Policy: We are the voice of the
industry on Beacon Hill & Capitol
Hill.
Economic Development: We
help members with:



Lab & office space
Tax incentives
Grants
Workforce Development: We
work with our sister organization,
MassBioEd on preparing the
workforce and filling the pipeline.
1
3
Advocacy
Economic Development & Global Affairs
About MassBio
Innovation Services
Assisting Companies
locate and grow in MA
Business Development
Access to the Network
Savings
Promoting the
Massachusetts Cluster
Advocacy
• BioLeads Meetings
• Guidance on incentives
• Case management
• 50+ active leads on average
• Marketing materials
• Trade missions/BIO
• Coordination with state agencies
Get Started
Competitiveness
• EDAG Initiatives
• BioReady TM Communities
(October 2009)
Dracut
Greenfield
Gardner
Hatfield
Haverhill
Newburyport
Lawrence
North Andover
Andover
Gloucester
Beverly
Salem
Billerica
Reading
Bedford
Burlington
Lynn
Lexington
Waltham
Chelsea
Framingham
Worcester
Watertown
Newton
Boston
Holliston
Dedham
Grafton
Norfolk
Northbridge
Canton
Franklin
Tri-Town (Southfield)
Randolph
Mansfield
Brockton
Fitchburg
Leominster
Pittsfield
Lowell
Chelmsford Tewksbury
Devens
Marlborough
Easthampton
Northampton
Holyoke
Chicopee
Westfield
Springfield
Sturbridge
Cambridge
Everett
Somerville
West Bridgewater
Attleboro
Taunton
Platinum
Gold
Fall River
New Bedford
Silver
Bronze
Industry Data & Analysis
Global Relationships
• Annual Industry Snapshot
• Industry data for members
• 17 Foreign agency members
• Host 20 delegations annually
MassBio Leading Job Listings as % of Total Listings
12.0%
10.0%
8.0%
Feb. 08
Sept. 08
Feb. 09
, 2001-2008*
Sept.yment
09
gy Emplo
tts Biotechnolo
Massachuse
6.0%
4.0%
2.0%
50,000
0.0%
l
ch
ar
lat
or
y
Re
se
Re
gu
l
e
nc
ca
nt
ro
Co
su
ra
ty
As
ali
ty
Qu
/IT
rin
g
IS
ini
tu
m
en
t
Cl
lop
ve
Pr
e-
an
uf
ac
De
M
ali
s
es
Pr
oc
35,000
Qu
l
t
y
er
en
ov
pm
sc
Di
ve
lo
ug
De
Dr
ug
Bi
40,000
Dr
ry
gy
ica
olo
Cl
in
m
ist
Bi
Ch
em
he
oc
ist
45,000
42.6%
Growth
Since
2001
30,000
25,000
20,000
15,000
10,000
2001
2002
2003
2004
2005
2006
2007
2008
MassBio
Economic Development
&
Global Affairs
MassBio assists the growth of the biotechnology industry in Massachusetts by:
* pursuing strategies to maintain/improve the competitiveness of the cluster; and
* providing direct services to biotech companies considering entry to or expansion in Massachusetts.
Why Massachusetts?
550
430+
Biopharma
Biotech
Companies
9 of the Top 18
Top 5
122
NIH funded
NIH funded
Research
Research
Hospitals
Hospitals
Colleges &
Universities
1st in
1st in
Education
Level of
workforce (US)
Workforce
Venture Capital
& federal
SBIR funds
research
per worker
funds
per worker
Supportive
Local, State Government
Life Sciences Initiative
Biotech Caucus
The $1 Billion Massachusetts Life Sciences Initiative – Enacted in 2008
Over time, the
industry
demonstrated its
value,
commitment to
the region, and
promise for the
future . . . and
state
government
responded.
• 10
years
• $1 billion
Investment
III. History
Kendall Square, 1960
Kendall Square, 1970
60%
$564 million
2013 NIH Research Funding - Longwood Medical Area - Bo
Brigham and Women’s $315,919,592
Harvard Medical School $200,413,466
Children’s Hospital Boston $126,812,298
Dana Farber Cancer Institute $115,844,948
Beth Israel Deaconess $118,785,811
Harvard School of Public Health
$120,611,357
2013 World Series Champions
Industry
History
Massachusetts Biotech Timeline
1953
Double helix of DNA explained by Watson & Crick
Biogen founded
1978
1980
1981
1985
U.S. Supreme Court approves patenting of recombinant life forms,
Passage of Bayh-Dole Act
Genzyme founded
MassBio becomes the 1st biotechnology
industry association
Map of the human genome is completed
Novartis locates Global Research HQ in Cambridge, MA
2000
2002
2003
MassBio issues Biotech 2010 Report
BMS chooses to build $1b facility in Devens, MA
2006
2008
$1 B Massachusetts Life Sciences Initiative enacted
Experienced Leadership: Network Effect in Industry
Hyperion
Therapeutics
bluebird bio
Five Prime
Therapeutics
Antigenetics
FFE
Therapeutics
Thrombolytic
Science
International
Zyngenia
Hydra
Biosciences
Talent
Predictive
Biosciences
Exact
Sciences
Corp
Declion
Holdings
OvaScience
Peptimmune
Catabasis
Verastem
rEVO
Biologics
Candela
Aronex
PureTech
Ventures
Glyco
Solutions
Genzyme
GTC
Biotherapeutics
Cubist
OXiGENE
Proteon
Therapeutics
Ocular
Therapeutix
Abazyme
Sarepta
Novavax
Intercell
Flatley
Discovery Lab
Patho
Genetix
Procept
Gallus
Biopharmaceuticals
Viscus
Biologics
TetraLogic
Columbia
Laboratories
Red Sky
Partners
Link Medical
Group
Neuron
Systems
Aldexa
Therapeutics
CXO Position
after Genzyme
1st
2nd
3rd
4th
Note: Representative sample of previous Genzyme employees with CXO title at companies joined after Genzyme. 43 companies excluding Genzyme.
Source: Health Advances analysis, LinkedIn.
Cluster Analysis
CONFIDENTIAL — November 2013
— DRAFT —
23
Experienced Leadership : Non-profit Research
Company
Creation
Acusphere
AIR
Arsenal
BIND Biosciences
Blend Therapeutics
Echo Therapeutics
Enzytech (Acq. by Alkermes)
Gecko Biomedica
InVivo Therapeutics
Kala
Living Proof
Microchips
Moderna
Momenta
PixarBio
Pervasis
Pulmatrix
Selecta Biosciences
Seventh Sense
SQZ Biotech
Taris
Transform
T2
http://www.polarispartner
s.com/about/strategy/rep
eat-entrepreneurs/
Networks: Entrepreneurs
Associate Professor
Harvard Medical School
Omid Farokhzad, M.D.
Director, Laboratory of
Nanomedicine and Biomaterials,
Brigham & Women’s Hospital
Bind Therapeutics
Selecta Biosciences
Blend Therapeutics